Dynamine (methylliberine) is not outright banned in most countries, but it sits in a regulatory gray zone that has led to restrictions in certain contexts. It is not explicitly listed on the World Anti-Doping Agency (WADA) Prohibited List, and it remains available in dietary supplements in the United States. However, its chemical similarity to other stimulants has raised flags with sports organizations and drug regulators in several countries, creating confusion about its legal status.
Dynamine’s Complicated Status in Sports
The most common reason people encounter the idea that Dynamine is “banned” relates to competitive sports. WADA does not explicitly name methylliberine on its Prohibited List. However, researchers analyzing brain-boosting supplements have classified Dynamine’s status as “unclear,” noting it is “presumed to meet WADA criteria” for prohibition. The reason: its chemical structure and biological effects are similar enough to substances that are on the banned list that it could be flagged under WADA’s catch-all rules.
WADA’s Prohibited List includes broad categories, not just individual compounds. A substance can be prohibited if it shares a similar chemical structure or similar biological effect to something already listed, even if it’s never mentioned by name. Dynamine is a purine alkaloid closely related to caffeine and theacrine, and while caffeine itself was removed from the WADA banned list in 2004, other stimulants in the same chemical neighborhood remain prohibited. This leaves athletes in a difficult position: Dynamine may or may not trigger a violation depending on how testing agencies interpret the rules.
For competitive athletes, “unclear” is functionally the same as “risky.” Many sports nutrition advisors treat Dynamine as something to avoid before competition, even without an explicit ban. The NCAA and various national anti-doping agencies maintain their own lists, and the lack of clarity around Dynamine means athletes can’t be confident it won’t cause problems.
Why Australia Flagged Dynamine
Australia’s Therapeutic Goods Administration (TGA) has taken a notably cautious stance. In a consultation document on sports supplements, the TGA identified Dynamine as a “novel substance with an unknown safety profile,” grouping it alongside synthetic caffeine derivatives. Australia classifies it as a “relevant substance,” meaning it isn’t included in the country’s Poisons Standard but also isn’t cleared for use.
The TGA’s concern isn’t that Dynamine has been proven dangerous. It’s that not enough is known about it. Australia takes a precautionary approach to supplements: if a compound is novel and lacks a long track record of safe use, regulators treat it with suspicion. For Australians, this effectively means Dynamine-containing products may not be legally sold as dietary supplements without further regulatory approval.
The U.S. Regulatory Picture
In the United States, Dynamine occupies a more permissive space. It is sold in pre-workout supplements and energy products without FDA enforcement action. The supplement industry in the U.S. operates under a different framework than in Australia or Europe. Manufacturers can self-affirm that an ingredient is “Generally Recognized as Safe” (GRAS) based on expert review, without needing direct FDA approval before selling it.
That said, the FDA has not publicly confirmed Dynamine’s safety through its own review process. The distinction matters: a self-affirmed GRAS status means a panel of experts hired by the manufacturer concluded the ingredient is safe, but the FDA hasn’t independently verified that conclusion. This is the same pathway many supplement ingredients follow in the U.S., and it’s one reason the American supplement market includes compounds that other countries restrict.
What Dynamine Actually Does in the Body
Dynamine is a methylated derivative of a compound found naturally in kucha tea leaves and certain coffee species. It works through similar pathways as caffeine, primarily by interacting with adenosine receptors in the brain. Adenosine is the chemical that builds up throughout the day and makes you feel sleepy. By blocking those receptors, Dynamine promotes wakefulness and alertness, much like caffeine does. It also appears to influence dopamine signaling, which affects mood and motivation.
The key difference from caffeine, at least in theory, is speed and duration. Dynamine is marketed as having a faster onset and shorter duration of action, giving a quick energy boost without the prolonged stimulation that can interfere with sleep. This profile is what makes it attractive for pre-workout formulas, but it’s also what draws regulatory scrutiny. Fast-acting stimulants that affect dopamine pathways tend to get more attention from anti-doping and safety regulators than slower, milder compounds.
What the Safety Data Shows
The published human research on Dynamine is limited but generally reassuring at the doses studied. A randomized trial of 125 young adults tested doses of 100 mg and 150 mg daily, both alone and combined with theacrine (a related compound), over four weeks. Heart rate, blood pressure, and heart electrical activity were all monitored throughout.
Heart rate showed a small decrease over the study period but stayed well within the normal range of 60 to 100 beats per minute. Blood pressure showed a slight downward trend rather than the increase you might expect from a stimulant. Heart rhythm monitoring revealed no abnormal changes in any group, with electrical measurements staying within the threshold regulators use to flag cardiac concerns. The researchers concluded that Dynamine “does not appear to negatively affect markers of health over four weeks of continuous use” at these doses.
A separate study looking at mood and cognitive effects found similar results: no adverse events were reported, heart rate decreased slightly after four days of supplementation, and diastolic blood pressure was actually lower in the Dynamine group than the placebo group after two hours. Both studies were small and short-term, which is part of the problem. Regulators in countries like Australia want longer and larger safety datasets before they’re comfortable clearing a novel stimulant.
Why the Confusion Exists
Much of the “Dynamine is banned” narrative comes from its guilt by association. The sports supplement industry has a history of including stimulants that were later pulled from the market, most notably DMAA and DMHA. These compounds were linked to serious cardiovascular events and eventually faced regulatory crackdowns. Dynamine entered the market in that same post-DMAA era, and consumers understandably wonder whether it’s the next ingredient to face a ban.
Dynamine is chemically distinct from DMAA and DMHA. Those compounds are alkylamines that directly stimulate the release of norepinephrine, essentially triggering a fight-or-flight response. Dynamine is a purine alkaloid, structurally closer to caffeine than to amphetamine-like stimulants. The mechanism and the risk profile are different. But when you see a new stimulant in a pre-workout with aggressive branding, the instinct to assume it’s in the same category is understandable.
The bottom line is that Dynamine’s regulatory status depends entirely on where you are and what you’re doing. If you’re a recreational gym-goer in the United States, it’s legal and available. If you’re a competitive athlete subject to drug testing, its unclear WADA status makes it a gamble. And if you’re in Australia, regulators have flagged it as a novel substance they haven’t approved. The word “banned” oversimplifies a situation that is really about incomplete data and cautious regulators waiting for more evidence.